Latest News
- Alert FDA OKs Elacestrant for ESR1+ Advanced, Metastatic Breast Cancer
- Alert FDA Approves Pirtobrutinib for R/R Mantle Cell Lymphoma
- Even One Head Injury Boosts All-Cause Mortality Risk
- CV Deaths Jumped in 2020, Reflecting Pandemic Toll
- New Imaging Score May Predict Chemo Benefit in Early OPSCC
- Long COVID Affecting More Than 33% of College Students, Faculty
- FDA to Ease Blood Donation Restrictions for Gay, Bisexual Men
- 'Kafkaesque Nightmare': Judge Wants Researcher Reinstated
- Proof Lacking for Dual-Targeted Therapy Benefit in IBD
- How Should PRAME Be Used to Evaluate Melanocytic Lesions?
- Female Doctors Have Higher Infertility Rates: What Can Be Done?
- Pediatricians, Specialists Largely Agree on ASD Diagnoses
- Food Additives May Exacerbate IBD
- Novavax Needs 6 Months to Produce Annual COVID Shots That Match New Variants
- Which Populations Should Be Screened for Cervical Cancer?
- Disparities in Breast Cancer Deaths, MRI Screening Persist
- California Law Aiming to Curb COVID Misinformation Blocked by Judge
- Staffing Woes Set to Weigh on Hospital Operator's Profits
- Income Could Plunge for Out-of-Network Doctors
- Biosimilar Equal to Natalizumab for Relapsing-Remitting MS